Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

AC Immune S.A. (ACIU)

AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 199,816
  • Shares Outstanding, K 100,410
  • Annual Sales, $ 31,020 K
  • Annual Income, $ -57,840 K
  • EBIT $ -60 M
  • EBITDA $ -57 M
  • 60-Month Beta 1.23
  • Price/Sales 6.41
  • Price/Cash Flow N/A
  • Price/Book 1.54

Options Overview Details

View History
  • Implied Volatility 169.20% ( -124.15%)
  • Historical Volatility 53.40%
  • IV Percentile 65%
  • IV Rank 42.98%
  • IV High 357.22% on 04/19/24
  • IV Low 27.45% on 08/05/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 36
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 949
  • Open Int (30-Day) 1,095

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -4.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.9500 +2.56%
on 03/26/25
2.5900 -22.78%
on 02/28/25
-0.5500 (-21.57%)
since 02/27/25
3-Month
1.9500 +2.56%
on 03/26/25
3.0900 -35.36%
on 01/06/25
-0.7300 (-26.74%)
since 12/27/24
52-Week
1.9500 +2.56%
on 03/26/25
4.9800 -59.82%
on 06/07/24
-1.0300 (-33.99%)
since 03/27/24

Most Recent Stories

More News
New Strong Buy Stocks for January 31st

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:EnerSys (ENS): This energy storage solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing...

ACIU : 2.0000 (+0.50%)
SFIX : 3.40 (-2.86%)
MC : 59.66 (-3.20%)
SOPA : 1.0100 (-0.98%)
AC Immune Reports Positive Interim Safety Data for ACI-24.060 in Down Syndrome Phase 1b/2 ABATE Trial

AC Immune reports positive interim safety data for ACI-24.060 in Down syndrome, showing no serious adverse events noted.Quiver AI SummaryAC Immune SA announced positive interim safety data from its Phase...

ACIU : 2.0000 (+0.50%)
AC Immune: Q3 Earnings Snapshot

AC Immune: Q3 Earnings Snapshot

ACIU : 2.0000 (+0.50%)
AC Immune: Q2 Earnings Snapshot

AC Immune: Q2 Earnings Snapshot

ACIU : 2.0000 (+0.50%)
AC Immune: Q1 Earnings Snapshot

AC Immune: Q1 Earnings Snapshot

ACIU : 2.0000 (+0.50%)
AC Immune: Q3 Earnings Snapshot

AC Immune: Q3 Earnings Snapshot

ACIU : 2.0000 (+0.50%)
AC Immune: Q2 Earnings Snapshot

AC Immune: Q2 Earnings Snapshot

ACIU : 2.0000 (+0.50%)
Why Shares of AC Immune Jumped This Week

The FDA has granted a Fast Track Designation to its Alzheimer's disease vaccine candidate.

ACIU : 2.0000 (+0.50%)
AC Immune: Q1 Earnings Snapshot

AC Immune: Q1 Earnings Snapshot

ACIU : 2.0000 (+0.50%)
Is Ardelyx is A Buy After Slip in Early 2022

Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them

ARDX : 5.14 (+1.98%)
CNCE : 8.37 (+0.12%)
KYKOF : 14.7500 (+8.06%)
SFOSF : 1.9450 (+2.37%)
KHTRF : 4.2000 (-0.76%)
ACIU : 2.0000 (+0.50%)
BMEA : 2.49 (-1.19%)

Business Summary

AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta...

See More

Key Turning Points

3rd Resistance Point 2.1200
2nd Resistance Point 2.0900
1st Resistance Point 2.0400
Last Price 2.0000
1st Support Level 1.9600
2nd Support Level 1.9300
3rd Support Level 1.8800

See More

52-Week High 4.9800
Fibonacci 61.8% 3.8200
Fibonacci 50% 3.4600
Fibonacci 38.2% 3.1100
Last Price 2.0000
52-Week Low 1.9500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar